Sanara MedTech (SMTI) Metrics: History & Chart

Sanara MedTech Inc.(SMTI)

Medical - Instruments & Supplies · Fort Worth, TX

$35.00Daily change unavailable

Delayed quote: Oct 6, 2026, 3:40 PM EDT

About Sanara MedTech Inc.

Sanara MedTech Inc. is a Fort Worth, Texas-based company established in 2001, dedicated to the development, marketing, and distribution of advanced wound and skin care products. These solutions are provided to a diverse clientele within the United States healthcare sector, including physicians, hospitals, clinics, and post-acute care facilities. The company's extensive product portfolio includes CellerateRX, a line of Surgical Activated Collagen in both powder and gel forms, designed to enhance patient healing across various surgical specialties. Sanara MedTech also offers a suite of Biako's antimicrobial products: a patented Skin and Wound Cleanser engineered to dismantle mature biofilm microbes by disrupting their extracellular polymeric substances, an Antimicrobial Wound Gel effective against both planktonic and biofilm-forming microbes, and an Antimicrobial Skin and Wound Irrigation Solution. Another key offering is HYCOL, a hydrolyzed Type I bovine collagen available as powder and gel, specifically formulated for the management of both full and partial thickness wounds, encompassing conditions such as pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. Additionally, Sanara MedTech is involved in the development of sophisticated biologic devices like FORTIFY TRG, a freeze-dried, multi-layer sheet derived from small intestinal submucosa extracellular matrix, and FORTIFY FLOWABLE extracellular matrix, an innovative wound care solution. The company also provides VIM Amnion Matrix, a single-layer amnion tissue sheet. Initially incorporated as WNDM Medical Inc., the company underwent a name change to Sanara MedTech Inc. in May 2019.

Fort Worth, TX

108 employees

sanaramedtech.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Seth D. Yon

View full financials

Third-Party DCF Estimate (FMP)	$50.91
Price Gap vs Third-Party Estimate	+45.42%

7D Total Return	-0.28%
30D Total Return	+0.78%
YTD Total Return	+49.89%
1Y Total Return	+12.22%
3Y Total Return	+13.50%
5Y Total Return	+1.76%
10Y Total Return	+775.25%
15Y Total Return	+16.62%
20Y Total Return	+249.73%

2026	+49.89%
2025	-29.67%
2024	-19.22%
2023	-9.67%
2022	+53.98%
2021	-40.78%
2020

CAGR TTM	+12.15%
CAGR 3Y	+4.31%
CAGR 5Y	+0.35%
CAGR 10Y	+24.23%
CAGR 15Y	+1.03%
CAGR 20Y	+6.46%

PE Ratio	18.32
PE Ratio Avg TTM	16.56
PE Ratio Avg 3Y	19.19
Current VS TTM Avg	+10.62%
Current VS 3Y Avg	-4.56%
Current VS 5Y Avg	-4.56%

All Metrics

SMTI Valuation Metrics

SMTI Stock Price Metrics

SMTI Dividend Metrics

SMTI Growth Rate Metrics

SMTI Discounted Cash Flow Metrics

SMTI Returns By Period

SMTI Yearly Returns

SMTI Average Annual Returns By Period (CAGR)

SMTI Revenue Metrics

SMTI PE Ratio Metrics

SMTI PS Ratio Metrics

SMTI PB Ratio Metrics

SMTI Price to Free Cash Flow Ratio Metrics

SMTI Debt to Equity Ratio Metrics

SMTI PEG Ratio Metrics

SMTI FCF Yield

SMTI Earnings Yield

SMTI EBITDA Yield

SMTI OCF Yield

SMTI EV/EBIT Ratio Metrics

SMTI EV/EBITDA Ratio Metrics

SMTI EV/Assets Ratio Metrics

SMTI EV/Sales Ratio Metrics

SMTI Current Ratio Metrics

SMTI Quick Ratio Metrics

SMTI ROIC Metrics

SMTI Return on Assets Metrics

SMTI Return on Equity Metrics

SMTI Net Profit Margin Metrics

SMTI Gross Profit Margin Metrics

SMTI Tax Rate Metrics

PS Ratio	2.76
PS Ratio Avg TTM	2.10
PS Ratio Avg 3Y	3.21
Current VS TTM Avg	+31.58%
Current VS 3Y Avg	-13.89%
Current VS 5Y Avg	-46.12%

PB Ratio	38.17
PB Ratio Avg TTM	31.92
PB Ratio Avg 3Y	14.21
Current VS TTM Avg	+19.60%
Current VS 3Y Avg	+168.53%
Current VS 5Y Avg	+458.68%

PFCF Ratio	67.32
PFCF Ratio Avg TTM	68.50
PFCF Ratio Avg 3Y	1526.97
Current VS TTM Avg	-1.73%
Current VS 3Y Avg	-95.59%
Current VS 5Y Avg	-95.59%

Debt/Equity Ratio	6.11
Debt/Equity Ratio Avg TTM	6.02
Debt/Equity Ratio Avg 3Y	2.63
Current VS TTM Avg	+1.42%
Current VS 3Y Avg	+132.21%
Current VS 5Y Avg	+1782.57%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	1.49%
FCF Yield Avg TTM	1.48%
FCF Yield Avg 3Y	1.01%
Current VS TTM Avg	+0.72%
Current VS 3Y Avg	+47.86%
Current VS 5Y Avg	+47.86%

Earnings Yield	5.46%
Earnings Yield Avg TTM	6.55%
Earnings Yield Avg 3Y	5.61%
Current VS TTM Avg	-16.58%
Current VS 3Y Avg	-2.71%
Current VS 5Y Avg	-2.71%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	32.71
Ev/Ebit Ratio Avg TTM	44.92
Ev/Ebit Ratio Avg 3Y	44.92
Current VS TTM Avg	-27.18%
Current VS 3Y Avg	-27.18%
Current VS 5Y Avg	-27.18%

Ev/Ebitda Ratio	26.34
Ev/Ebitda Ratio Avg TTM	25.05
Ev/Ebitda Ratio Avg 3Y	38.77
Current VS TTM Avg	+5.16%
Current VS 3Y Avg	-32.06%
Current VS 5Y Avg	-32.06%

Ev/Assets Ratio	4.86
Ev/Assets Ratio Avg TTM	3.30
Ev/Assets Ratio Avg 3Y	3.55
Current VS TTM Avg	+47.22%
Current VS 3Y Avg	+36.99%
Current VS 5Y Avg	+16.53%

Ev/Sales Ratio	3.06
Ev/Sales Ratio Avg TTM	2.41
Ev/Sales Ratio Avg 3Y	3.41
Current VS TTM Avg	+26.96%
Current VS 3Y Avg	-10.35%
Current VS 5Y Avg	-39.29%

Current Ratio	2.58
Current Ratio Avg TTM	2.14
Current Ratio Avg 3Y	1.98
Current VS TTM Avg	+20.24%
Current VS 3Y Avg	+30.23%
Current VS 5Y Avg	+21.09%

Quick Ratio	2.30
Quick Ratio Avg TTM	1.91
Quick Ratio Avg 3Y	1.70
Current VS TTM Avg	+20.19%
Current VS 3Y Avg	+35.06%
Current VS 5Y Avg	+18.34%

ROIC	18.15%
ROIC Avg 3Y	(2.15%)
ROIC Avg 5Y	(10.08%)
Current VS 3Y Avg	+945.69%
Current VS 5Y Avg	+279.94%
Current VS 10Y Avg	+221.71%

ROA	(46.30%)
ROA Avg TTM	(9.40%)
ROA Avg 3Y	(2.08%)
Current VS TTM Avg	-392.36%
Current VS 3Y Avg	-2122.72%
Current VS 5Y Avg	-1591.88%

ROE	(403.03%)
ROE Avg TTM	(430.56%)
ROE Avg 3Y	(177.34%)
Current VS TTM Avg	+6.39%
Current VS 3Y Avg	-127.26%
Current VS 5Y Avg	-1936.97%

Net Profit Margin	(29.15%)
Net Profit Margin Avg TTM	(25.82%)
Net Profit Margin Avg 3Y	(7.85%)
Current VS TTM Avg	-12.91%
Current VS 3Y Avg	-271.56%
Current VS 5Y Avg	-183.29%

Gross Profit Margin	91.33%
Gross Pft Margin Avg TTM	91.55%
Gross Pft Margin Avg 3Y	90.46%
Current VS TTM Avg	-0.24%
Current VS 3Y Avg	+0.96%
Current VS 5Y Avg	+1.13%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	+100.00%